Skip to main content Skip to section navigation Skip to footer
VolitionRx Ltd
  • Our Technology
    • Nu.Q® Technology Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
      • Our Tests
      • Human Health
      • Nu.Q® NETs Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
      • Nu.Q® Discover Buy our Nu.Q® Discover H3.1 Research Use Only Assay
      • Animal Health
      • Nu.Q® Vet Cancer Test Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
      • Our Service
      • Nu.Q® Discover Nu.Q® Discover gives you access to a range of assays, built on our proprietary Nucleosomics™ platform, for rapid epigenetic profiling in disease model development, preclinical testing and clinical studies.
      • Our Pipeline Development
      • Nu.Q® Cancer We are developing a range of blood-based assays with potential applications beyond cancer detection.
      • Breakthrough Cancer Detection Method We have developed a novel method for liquid biopsy enabling rapid, cost-effective cancer detection in a routine blood test.
  • Human Health
    • Cancer
    • Sepsis
  • Nu.Q® Products
    • Nu.Q® NETs Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
    • Nu.Q® Discover Buy our Nu.Q® Discover H3.1 Research Use Only Assay
    • Nu.Q® Vet Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
  • Resources
    • Press Releases Latest news on Volition and our products.
    • Scientific Resources for educational and research purposes.
    • Events & Webinars Resources for educational and research purposes.
    • Media Toolkit & Downloads Our library for images and educational downloads.
    View all resources
  • About
    • Our Company Volition means to have determination and a purpose.
    • Our Team Get to know our team of experts behind our research and products.
    • Careers We’re always looking for talented individuals to join our mission.
  • Investors
Join Mailing List

Investor Relations

Press Releases.

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Video Gallery
    • IR Calendar
    • Presentations & Reports
    • Email Alerts
    • Shareholders Letters
  • Company Info
    • Company Profile
    • Executive Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • Video Gallery
  • IR Calendar
  • Presentations & Reports
  • Email Alerts
  • Shareholders Letters
Nov 12, 2020 4:10 pm EST

VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business Update

Nov 10, 2020 8:00 am EST

Volition Veterinary Presents Expert Report Ahead of First Product Launch

Nov 9, 2020 8:00 am EST

VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update

Oct 21, 2020 8:00 am EDT

VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020

Oct 20, 2020 7:00 am EDT

VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020

Oct 16, 2020 8:00 am EDT

Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference

Oct 14, 2020 8:00 am EDT

VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020

Oct 12, 2020 8:00 am EDT

Volition Veterinary Diagnostics Development LLC to Present Product Data Regarding its Nu.Q™ Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference

Sep 29, 2020 8:00 am EDT

VolitionRx Limited Announces Virtual Capital Markets Day 2020

Sep 1, 2020 8:00 am EDT

VolitionRx Limited to Present at Conferences in September 2020

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • …
  • Page 38
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
logo
  • Nu.Q® Technology
  • Nu.Q® NETs
  • Nu.Q® Vets
  • Nu.Q® Discover
  • Nu.Q® Cancer
  • Disease Areas
  • Cancer
  • Sepsis
  • Resources
  • Blog
  • Scientific
  • Investors
  • Veterinary Resources
  • Company
  • About Us
  • Our Expert Team
  • Careers

Our mission is to save lives and improve outcomes for millions of people and animals worldwide.

Looking for Investor Updates and Press Releases?
Click here

  • eIFU Resources
  • Privacy Policy
  • Cookies Policy
  • Disclaimer
  • © 2025 Web Agency London
  • Twitter
  • Facebook
  • Linkedin

The European regional development fund and Wallonia are investing in your future.

http://europe.wallonie.be

  • logo-eu
  • logo-wallonie
Back to top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Powered by GDPR Cookie Compliance
Privacy Overview

Some cookies are strictly necessary for the proper functioning of the website. Therefore you cannot unclick the corresponding box if you wish to visit the website. Other cookies are used for statistics and marketing purposes. We will not place them unless you agree by ticking the corresponding box. Here is a link our cookie policy.

Strictly Necessary Cookies

Cookies that the site cannot function properly without. This includes cookies for access to secure areas and CSRF security. Please note that Craft’s default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.

Statistics Cookies

Statistic cookies help us understand how visitors interact with websites by collecting and reporting information anonymously.

Marketing Cookies

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.